Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001102624-13-000213
Filing Date
2013-02-20
Accepted
2013-02-19 17:32:41
Documents
10
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 AEOLUS 10-Q aeolus10q.htm 10-Q 513595
2 EXHIBIT 31.1 exh31_1.htm EX-31.1 14856
3 EXHIBIT 31.2 exh31_2.htm EX-31.2 14052
4 EXHIBIT 32.1 exh32_1.htm EX-32.1 12231
  Complete submission text file 0001102624-13-000213.txt   3209033

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aols-20121231.xml EX-101.INS 481502
6 XBRL TAXONOMY EXTENSION SCHEMA aols-20121231.xsd EX-101.SCH 25541
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aols-20121231_cal.xml EX-101.CAL 25723
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aols-20121231_def.xml EX-101.DEF 51206
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aols-20121231_lab.xml EX-101.LAB 193824
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aols-20121231_pre.xml EX-101.PRE 143800
Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Filer) CIK: 0001261734 (see all company filings)

EIN.: 561953785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50481 | Film No.: 13624507
SIC: 2834 Pharmaceutical Preparations